April 27, 2026 a 04:38 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. continues to be a strong player in the market for minimally invasive medical products, driven by its innovative da Vinci Surgical System and Ion endoluminal system. Despite a dynamic market, the company maintains robust support from analysts, showcasing strong buy sentiments.
Historical Stock Grades
The latest analyst ratings for Intuitive Surgical, Inc. indicate a dominant trend towards 'Buy' with significant support in the 'Strong Buy' category.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 7 | |
| Buy | 17 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
There is a noticeable fluctuation in the sentiment over past months. The 'Strong Buy' category experienced minor decreases, while 'Hold' ratings saw a minimal rise, suggesting a subtle shift towards caution.
- Strong Buy ratings slightly decreased from 8 to 7 over the past months.
- The Hold category experienced a minor increase, indicating a cautious sentiment.
- The overall number of ratings remains relatively stable, reflecting a consistent analyst interest.
Percentage Trends
The analysis of percentage trends reveals a moderate shift in sentiment. While the percentage of strong and buy recommendations has slightly decreased, 'Hold' recommendations are becoming more prevalent.
- April 2026: Strong Buy 16%, Buy 39%, Hold 21%, Sell and Strong Sell each at 2%.
- January 2026: Strong Buy 19%, Buy 38%, Hold 26%, Sell and Strong Sell each at 2%.
- The shift from Strong Buy to Hold may imply increased market caution.
- Recent months suggest a more cautious market stance with fewer assertive buy recommendations.
Latest Analyst Recommendations
The latest recommendations indicate continuity and strong confidence among analysts regarding Intuitive Surgical, Inc.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-23 | Overweight | Overweight | Barclays |
| 2026-04-22 | Overweight | Overweight | Piper Sandler |
| 2026-04-22 | Buy | Buy | BTIG |
| 2026-04-22 | Outperform | Outperform | Leerink Partners |
| 2026-04-22 | Outperform | Outperform | Baird |
Analyst Recommendations with Change of Opinion
Recent changes in analyst recommendations show a trend towards upgrades, signaling growing confidence in Intuitive Surgical, Inc.'s market prospects.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-11 | Buy | Neutral | Citigroup |
| 2026-01-27 | Buy | Hold | Freedom Capital Markets |
| 2026-01-26 | Buy | Hold | Freedom Broker |
| 2025-12-11 | Neutral | Buy | Citigroup |
| 2025-06-09 | Sell | Hold | Deutsche Bank |
Interpretation
The analyst sentiment towards Intuitive Surgical, Inc. remains fairly positive, although there is a cautious undertone as seen by the growing number of 'Hold' ratings. This could hint at increased scrutiny in the current market environment. Notable upgrades suggest confidence in the company's prospects. Overall, while there is stability in recommendations, the subtle shift towards a cautious outlook is indicative of broader market uncertainties.
Conclusion
Intuitive Surgical, Inc., supported by innovative technologies, continues to attract positive analyst sentiment. Despite slight caution evident in recent ratings, the general outlook remains optimistic. The combination of stable 'Buy' signals and recent upgrades point towards market confidence in the company. Investors should monitor this delicate balance between positive long-term prospects and near-term cautious sentiments.